Title:
癌の処置および検出において有用な101P3A11またはPHOR-1と名称が与えられる核酸および対応するタンパク質
Document Type and Number:
Japanese Patent JP2005512509
Kind Code:
A
Abstract:
A novel gene (designated 101P3A11 or PHOR-1) and its encoded, and variants thereof, are described wherein 101P3A11 exhibits tissue specific expression in normal adult tissue, and is aberrantly expressed in the cancers listed in Table I. Consequently, 101P3A11 provides a diagnostic, prognostic, prophylactic and/or therapeutic target for cancer. The 101P3A11 gene or fragment thereof, or its encoded protein, or variants thereof, can be used to elicit a humoral or cellular immune response; antibodies or T cells reactive with 101P3A11 can be used in active or passive immunization.
More Like This:
Inventors:
Jacobovitsu, Aya
Faris, mary
Leitano, Author Be.
Morrison, Robert Kendall
Saffron, douglas
GI, Wan Mao
Charita-Aid, Pia Em.
Faris, mary
Leitano, Author Be.
Morrison, Robert Kendall
Saffron, douglas
GI, Wan Mao
Charita-Aid, Pia Em.
Application Number:
JP2002589708A
Publication Date:
May 12, 2005
Filing Date:
May 15, 2002
Export Citation:
Assignee:
Agensis, Inc.
International Classes:
A01K67/027; A61K38/00; A61K39/395; A61K48/00; A61P35/00; C07K14/47; C07K16/18; C07K16/28; C07K16/46; C12N5/07; C12N5/0783; C12N5/09; C12N5/10; C12N15/09; C12P21/08; C12Q1/68; (IPC1-7): C12N15/09; A01K67/027; A61K38/00; A61K39/395; A61K48/00; A61P35/00; C07K14/47; C07K16/18; C07K16/46; C12N5/06; C12N5/10; C12Q1/68
Attorney, Agent or Firm:
Hidesaku Yamamoto
Takaaki Yasumura
Natsuki Morishita
Takaaki Yasumura
Natsuki Morishita